| Q37249726 | 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital |
| Q90413917 | A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study |
| Q30724746 | A combination of molecular markers and clinical features improve the classification of pancreatic cysts |
| Q88840834 | A prospective study of endoscopic ultrasonography features, cyst fluid carcinoembryonic antigen, and fluid cytology for the differentiation of small pancreatic cystic neoplasms |
| Q34375292 | A rare case of mixed mucinous cystadenoma with serous cystadenoma of the pancreas treated by laparoscopic central pancreatectomy |
| Q56379738 | ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts |
| Q93001657 | Advanced diagnostics for pancreatic cysts: Confocal endomicroscopy and molecular analysis |
| Q39031536 | Analysis of Pancreatic Cyst Fluid |
| Q38164260 | Approach to cystic lesions of the pancreas |
| Q42113218 | Appropriate Interval for Imaging Follow-up of Small Simple Pancreatic Cysts |
| Q53590334 | Are Clinical Guidelines for the Management of Intraductal Papillary Mucinous Neoplasms Followed?: A Single-Center Analysis. |
| Q90465359 | Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer |
| Q96817986 | Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center |
| Q93168148 | Clinical and radiological features that predict malignant transformation in cystic lesions of the pancreas: a retrospective case note review |
| Q26774489 | Clinical approach to incidental pancreatic cysts |
| Q34100230 | Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas |
| Q36195609 | Comparison of Endoscopic Ultrasonography, Computed Tomography, and Magnetic Resonance Imaging for Pancreas Cystic Lesions |
| Q33652032 | Comparison of endoscopic ultrasound, computed tomography and magnetic resonance imaging in assessment of detailed structures of pancreatic cystic neoplasms |
| Q55292571 | Comparison of guidelines for intraductal papillary mucinous neoplasm: What is the next step beyond the current guidelines? |
| Q42751815 | Concomitant pancreatic adenocarcinoma in a patient with branch-duct intraductal papillary mucinous neoplasm. |
| Q38765930 | Cross-sectional prevalence of pancreatic cystic lesions in patients with acromegaly, a single-center experience |
| Q26750210 | Current perspectives on pancreatic serous cystic neoplasms: Diagnosis, management and beyond |
| Q90149248 | Cyclooxygenase-2 and Cytosolic Phospholipase A2 Are Overexpressed in Mucinous Pancreatic Cysts |
| Q57141737 | Cyst Fluid Biomarkers - Diagnosis and Prediction of Malignancy for Cystic Lesions of the Pancreas |
| Q61535064 | Cystic Neoplasms of the Pancreas |
| Q37279916 | Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period |
| Q38203448 | Cystic neoplasms of the pancreas; findings on magnetic resonance imaging with pathological, surgical, and clinical correlation |
| Q35609914 | Cystic precursors to invasive pancreatic cancer |
| Q53260415 | Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. |
| Q37170334 | Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis |
| Q47880483 | Diagnosis and Management of Pancreatic Cystic Neoplasms |
| Q64108315 | Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions: 2017 Consensus Recommendations of the Korean Society of Abdominal Radiology |
| Q90135274 | Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines |
| Q64902640 | Diagnosis of intraductal papillary mucinous neoplasm using endoscopic ultrasound guided microbiopsies: A case report. |
| Q42430961 | Diagnostic Accuracy of 256-Detector Row Computed Tomography in Detection and Characterization of Incidental Pancreatic Cystic Lesions |
| Q52953175 | Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI. |
| Q94476197 | Diagnostic yield of EUS-guided through-the-needle microforceps biopsy versus EUS-FNA of pancreatic cystic lesions: a systematic review and meta-analysis |
| Q64284005 | Difference analysis in prevalence of incidental pancreatic cystic lesions between computed tomography and magnetic resonance imaging |
| Q39718778 | Differentiation of pancreatic cysts with optical coherence tomography (OCT) imaging: an ex vivo pilot study |
| Q37104275 | Diffusion-Weighted Magnetic Resonance Imaging in Distinguishing Between Mucin-Producing and Serous Pancreatic Cysts. |
| Q46011421 | Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results. |
| Q38662568 | Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms? |
| Q91563264 | EUS-FNA diagnosis of pancreatic serous cystadenoma with the aid of cell blocks and α-inhibin immunochemistry: A case series |
| Q90066129 | Early detection of pancreatic cancer |
| Q35225349 | Elevated erythropoietin and multicystic neoplasm of the pancreas |
| Q36315824 | Endoscopic ultrasonography evaluation for pancreatic cysts: Necessity or overkill? |
| Q38075465 | Endoscopic ultrasound and pancreatic applications: what the radiologist needs to know |
| Q37185377 | Endoscopic ultrasound characteristics of pancreatic lymphoepithelial cysts: A case series from a large referral center |
| Q37876077 | Endoscopic ultrasound for non-gastroenterologists: what you need to know |
| Q38238748 | Endoscopic ultrasound in the diagnosis and treatment of pancreatic disease. |
| Q38224446 | Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms |
| Q35453689 | Endoscopic ultrasound in the evaluation of pancreatic neoplasms-solid and cystic: A review |
| Q54457240 | Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) contributes to a triple-negative test in preoperative screening of pancreatic cysts. |
| Q26778647 | Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic cysts by combined cytopathology and cystic content analysis |
| Q60046413 | Endoscopic ultrasound-guided through-the-needle microforceps biopsy in the evaluation of pancreatic cystic lesions: a multicenter study |
| Q91672046 | Endoscopic ultrasound-through-the-needle biopsy in pancreatic cystic lesions: A large single center experience |
| Q35179268 | Endosonography in the diagnosis and management of pancreatic cysts |
| Q38842110 | Enhancing High Value Care in Gastroenterology Practice |
| Q35325612 | Epidemiology, diagnosis, and management of cystic lesions of the pancreas |
| Q33731992 | Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation |
| Q54943890 | European evidence-based guidelines on pancreatic cystic neoplasms. |
| Q53208028 | Fucosylation is associated with the malignant transformation of intraductal papillary mucinous neoplasms: a lectin microarray-based study. |
| Q39622483 | Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms |
| Q37589841 | GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs". |
| Q90427051 | Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue |
| Q46867228 | Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts |
| Q36089872 | Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins |
| Q90889983 | How Long Should Patients with Cystic Lesions of the Pancreas Be Followed? |
| Q39144837 | Imaging Pancreatic Cysts with CT and MRI. |
| Q34391272 | Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas |
| Q51175386 | Impact of Pancreatic Cyst Fluid CEA Levels on the Classification of Pancreatic Cysts Using the Papanicolaou Society of Cytology Terminology System for Pancreaticobiliary Cytology. |
| Q88028082 | Incidental Cystic Lesions in the Pancreas: Resect? EUS? Follow? |
| Q57640941 | Incidental pancreatic cyst: still a lot of road to cover |
| Q35100662 | Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality? |
| Q37530542 | Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: Large-scale, single-center cohort study |
| Q43209600 | Incidental, Small (< 3 cm), Unilocular, Pancreatic Cysts: Factors That Predict Lesion Progression during Imaging Surveillance |
| Q56773034 | Incidentally discovered benign pancreatic cystic neoplasms not communicating with the ductal system: MR/MRCP imaging appearance and evolution |
| Q37258340 | Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts |
| Q50092131 | Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes |
| Q28087395 | Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives |
| Q38690531 | Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management |
| Q57653260 | Light scattering spectroscopy identifies the malignant potential of pancreatic cysts during endoscopy |
| Q35067692 | Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms |
| Q57641781 | Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature? |
| Q46293540 | Longterm follow-up of small pancreatic cystic lesions in liver transplant recipients |
| Q41829224 | Magnetic resonance imaging and spectroscopy: how useful is it for prediction and prognosis? |
| Q38164996 | Magnetic resonance imaging of cystic pancreatic lesions in adults: an update in current diagnostic features and management |
| Q26796503 | Management of Incidental Pancreatic Cystic Lesions |
| Q37162358 | Management of Patients With Pancreatic Cysts: Analysis of Possible False-Negative Cases of Malignancy |
| Q53404638 | Measurement of pancreatic cystic lesions on magnetic resonance imaging: efficacy of standards in reducing inter-observer variability. |
| Q36447005 | Molecular Analyses of Aspirated Cystic Fluid for the Differential Diagnosis of Cystic Lesions of the Pancreas: A Systematic Review and Meta-Analysis |
| Q38143609 | Molecular diagnostics of pancreatic cysts |
| Q52585316 | Moray micro forceps biopsy improves the diagnosis of specific pancreatic cysts. |
| Q38270557 | Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization |
| Q48310994 | Mucinous cystic neoplasms of the pancreas: high-resolution cross-sectional imaging features with clinico-pathologic correlation. |
| Q87003228 | Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time |
| Q36609351 | Natural history of asymptomatic pancreatic cystic neoplasms. |
| Q92455132 | New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer |
| Q49485039 | New guidelines for use of endoscopic ultrasound for evaluation and risk stratification of pancreatic cystic lesions may be too conservative. |
| Q55710675 | New horizons in the endoscopic ultrasonography-based diagnosis of pancreatic cystic lesions. |
| Q39372245 | Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts. |
| Q38180627 | Non-neoplastic epithelial cysts of the pancreas: a rare, benign entity |
| Q38757526 | Novel Biomarkers for Pancreatic Cysts |
| Q92039154 | Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease |
| Q38798559 | Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations |
| Q90115907 | Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level: A Histopathologic Correlation |
| Q53088735 | Pancreatic MRI for the surveillance of cystic neoplasms: comparison of a short with a comprehensive imaging protocol. |
| Q64107925 | Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms |
| Q33970217 | Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults |
| Q57494390 | Pancreatic cyst: What clinician needs? |
| Q38893664 | Pancreatic cysts in general population on ultrasonography: Prevalence and development of risk score |
| Q36098501 | Pancreatic cysts suspected to be branch duct intraductal papillary mucinous neoplasm without concerning features have low risk for development of pancreatic cancer. |
| Q38021929 | Pancreatic cysts: a systematic approach and second look |
| Q34093790 | Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection |
| Q38858158 | Pancreatic surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it. |
| Q35829436 | Parenchyma-Sparing, Limited Pancreatic Head Resection for Benign Tumors and Low-Risk Periampullary Cancer--a Systematic Review |
| Q38138887 | Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram |
| Q39341924 | Prediction of malignancy in cystic neoplasms of the pancreas: a population-based cohort study |
| Q47245363 | Prevalence and outcomes of cystic lesions of the transplant pancreas: The University of Wisconsin Experience |
| Q49429125 | Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients |
| Q49168084 | Prevalence of incidental pancreatic cyst on upper endoscopic ultrasound. |
| Q35208634 | Prevalence of incidental pancreatic cysts on 3 tesla magnetic resonance |
| Q57646312 | Prevalence of pancreatic cystic neoplasms on imaging exams: association with signs of malignancy risk |
| Q26783953 | Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions |
| Q57767486 | RE: Proteomic Mucin Profiling for the Identification of Cystic Precursors of Pancreatic Cancer |
| Q27015932 | Rare nonneoplastic cysts of pancreas |
| Q35178284 | Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development |
| Q35659911 | Repeat abdominal imaging examinations in a tertiary care hospital. |
| Q53618459 | Research gaps in pancreatic cancer research and comparative effectiveness research methodologies. |
| Q96134822 | Role of Cross-sectional Imaging (CT/MRI) in Characterization and Distinguishing Benign from Malignant/Potentially Malignant Cystic Lesions of Pancreas |
| Q64266095 | Role of abdominal ultrasound for the surveillance follow-up of pancreatic cystic neoplasms: a cost-effective safe alternative to the routine use of magnetic resonance imaging |
| Q39144161 | Role of contrast harmonic-endoscopic ultrasound in pancreatic cystic lesions |
| Q38661563 | Role of emerging molecular markers in pancreatic cyst fluid |
| Q38161946 | Role of endoscopic ultrasonography in pancreatic cystic neoplasms: where do we stand and where will we go? |
| Q38661571 | Role of endoscopic ultrasound-guided fine-needle aspiration cytology, viscosity, and carcinoembryonic antigen in pancreatic cyst fluid |
| Q41977077 | Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy |
| Q92091255 | Single-session esophagogastroduodenoscopy and endoscopic ultrasound using a forward-viewing radial scan ultrasonic endoscope |
| Q38849083 | State-of-the-art endoscopic procedures for pancreatic cancer |
| Q35250233 | Surgery for cystic pancreatic lesions in the post-sendai era: a single institution experience |
| Q39249912 | Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection |
| Q33946877 | Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution |
| Q35214109 | Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model |
| Q26796693 | The Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management Choices |
| Q61817981 | The Impact of Repeating Endosonography with Confocal Endomicroscopy for the Diagnosis of Cystic Neuroendocrine Tumor |
| Q37156381 | The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting |
| Q38326191 | The genetic classification of pancreatic neoplasia. |
| Q36286489 | The incidental cystic pancreas mass: a practical approach |
| Q47093811 | The prevalence of pancreatic cystic lesions in patients with liver cirrhosis is double that in controls. |
| Q52909805 | The role of ancillary tests in the evaluation and management of patients with negative and non-diagnostic pancreatic cyst aspirates. |
| Q35450240 | The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas |
| Q37191275 | Therapeutic Approach to Cystic Neoplasms of the Pancreas |
| Q33641491 | Thermal ablation of pancreatic cyst with a prototype endoscopic ultrasound capable radiofrequency needle device: A pilot feasibility study |
| Q91794804 | Timing and Clinical Features of Spontaneous Decrease in Size of Small Pancreatic Cystic Lesions without High-Risk Stigmata |
| Q38135324 | To cease or 'de-cyst'? The evaluation and management of pancreatic cystic lesions |
| Q33780504 | To fine needle aspiration or not? An endosonographer's approach to pancreatic cystic lesions |
| Q42406070 | Update on pancreatic cyst fluid analysis |
| Q52553071 | Utility of transabdominal ultrasound for surveillance of known pancreatic cystic lesions: prospective evaluation with MRI as reference standard. |
| Q47240237 | Validation of Sendai and Fukuoka consensus guidelines in predicting malignancy in patients with preoperatively diagnosed mucinous pancreatic cystic neoplasms. |
| Q88733017 | Visceral adiposity and high adiponectin levels are associated with the prevalence of pancreatic cystic lesions |
| Q53175098 | What is the reasonable option for elderly patients with incidental pancreatic cystic neoplasms? Follow-up observation versus surgical resection. |
| Q38695381 | Which is the best current guideline for the diagnosis and management of cystic pancreatic neoplasms? An appraisal using evidence-based practice methods |
| Q35641254 | Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways |
| Q53622486 | [Classification and malignant potential of pancreatic cystic tumors]. |
| Q85484203 | [Pancreatic adenocarcinoma: 10 years of progress] |
| Q88852218 | [Resection of main duct and mixed type IPMN ≥5 mm] |